If you want to know the long-term side effects of the COVID-19 vaccines, pay close attention to Pfizer’s latest acquisitions. Since the rollout of their COVID-19 vaccine, Pfizer has acquired specific pharmaceutical companies that treat immune-inflammatory diseases, heart inflammation and various cancers. As their experimental use vaccine was being mandated on the population (including on the military) Pfizer was investing in drugs that target health conditions that were created and/or exacerbated by their experimental vaccines.
Pfizer acquired a drug company that treats immune-inflammatory diseases, including myocarditis
For instance, in 2021, Pfizer acquired Arena Pharmaceuticals. The price tag of the acquisition was disproportionate to the market size of the drug they acquired, but the shrewd Pfizer executive team knew the acquisition would be worth it in the end. By acquiring Arena Pharmaceuticals, Pfizer was able to control the future of therapeutics for various immune-inflammatory diseases, including drugs that address heart inflammation (myocarditis and pericarditis). These health problems skyrocketed after 2021, when Pfizer’s COVID-19 vaccines were unlawfully mandated on populations and haphazardly placed on the CDC’s childhood vaccine schedule. Today, Pfizer is profiting from health issues that they caused, keeping people in a state of illness and pharmaceutical dependence.
Pfizer acquires drug company that treats various cancers, capitalizing on the turbo cancer epidemic
By 2023, Pfizer spent $43 billion of their vaccine profits to acquire Seagen Pharmaceuticals, a little-known drug company that specializes in cancer treatments. Now, Pfizer is profiting from the surge in turbo cancers that are affecting vaccinated people of all age groups. Turbo cancer is a new phenomenon where oncologists describe a new wave of aggressive cancers that that kill people in weeks or days, as opposed to months or years. There’s no doubt that something is causing immunodeficiency. The very thing that populations were told to take to protect those with immunodeficiency has created an entire new class of people with immunodeficiency and turbo cancers. Meanwhile, their destructive biological weapons remain on the market, ensuring that these health issues continue to be profitable ventures for years to come.